| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $1.25B | -2.1% |
| Cost of Revenue | $141.4M | +8.7% |
| Gross Profit | $1.11B | -3.4% |
| R&D Expense | $261.2M | +3.0% |
| SG&A Expense | $275.3M | +22.8% |
| Operating Income | $206.6M | -40.0% |
| Interest Expense | $394K | -17.7% |
| Pre-tax Income | $215.3M | -39.3% |
| Income Tax | $31.4M |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $620.1M | -49.4% |
| Short-term Investments | $189.2M | +387.2% |
| Accounts Receivable | $243.6M | +4.7% |
| Inventory | $23.5M | +114.8% |
| Current Assets | $1.31B | -25.5% |
| Total Assets | $2.69B | -13.4% |
| Current Liabilities | $277.5M | -12.1% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $318.6M | -28.9% |
| Capital Expenditures | $47.9M | -12.0% |
| Investing Cash Flow | -$295.9M | -559.0% |
| Financing Cash Flow | -$610.6M | -141.8% |
| Free Cash Flow | $270.6M | -31.2% |
| -14.5% |
| Net Income | $184.1M | -40.7% |
| EPS (Basic) | $1.84 | -40.1% |
| EPS (Diluted) | $1.81 | -39.1% |
| Total Liabilities |
| $438.5M |
| -12.5% |
| Stockholders' Equity | $2.25B | -13.5% |